Abdominal Aortic Aneurysm Market Summary

• The Abdominal Aortic Aneurysm Market in the 7MM was valued at ~USD 1,579.9 Million in 2021, over the forecast period from 2024 to 2034.
• The Abdominal Aortic Aneurysm Market is projected to grow at a significant rate by 2034 in the leading countries (the US, EU4, UK, and Japan).

Abdominal Aortic Aneurysm Market and Epidemiology Analysis

• The total Abdominal Aortic Aneurysms diagnosed prevalent population in 7MM was estimated to be 1,641,380 cases in 2021 and is expected to increase in during the study period [2020–2034].  
• Total Abdominal Aortic Aneurysms diagnosed prevalent cases in the US was estimated to be 752,408 in 2021, which is the highest among all the 7MM countries.
• The US accounted for the highest Abdominal Aortic Aneurysms prevalent population among 7MM with 8,773 cases in 2021.
• Among the European five countries, the total Abdominal Aortic Aneurysms prevalent population is highest in Germany (192,532), followed by France (138,193), Italy (68,202) had the lowest prevalent cases among the EU-5 countries.
• The total Abdominal Aortic Aneurysms prevalent population in Japan was estimated to be 253,883 cases in 2021 and is expected to decrease during the forecast period [2023–2034].
• In the US, the highest number of cases were found to be having Small Abdominal Aortic Aneurysms (3 cm to 4.4 cm across) (696,730 cases) in 2021. Large Abdominal Aortic Aneurysm (5.5 cm or more across) were found in the least number of cases, i.e. 3,010 cases in 2021. Around 60,193 cases had Medium Abdominal Aortic Aneurysm (4.5 cm to 5.4 cm across) in 2021. These cases are expected to increase in the forecast period. 

Factors Impacting the Abdominal Aortic Aneurysm Market Growth

• Rising Prevalence of Cardiovascular Disorders

The growing burden of cardiovascular diseases, particularly among aging populations, is driving the demand for effective abdominal aortic aneurysm (AAA) management solutions, fueling market growth globally.

• Increasing Geriatric Population

As life expectancy increases, the prevalence of age-related conditions such as abdominal aortic aneurysm rises. The expanding elderly population directly boosts the market demand for AAA treatment options.

• Technological Advancements in Surgical Procedures

The adoption of advanced minimally invasive procedures, such as endovascular aneurysm repair (EVAR), provides safer, quicker recovery options for patients, driving greater acceptance and market expansion.

DelveInsight’s ‘Abdominal Aortic Aneurysm Treatment Market Insights, Epidemiology, and Market Forecast–2034’ report delivers an in-depth understanding of the Abdominal Aortic Aneurysm historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. 

The Abdominal Aortic Aneurysm Treatment Market Report provides current treatment practices, emerging drugs, and market share of individual therapies, and current and forecasted 7MM Abdominal Aortic Aneurysm market size. The Report also covers current Abdominal Aortic Aneurysm treatment market practices, Abdominal Aortic Aneurysm market drivers, market barriers, SWOT analysis, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

Abdominal Aortic Aneurysm Disease Understanding

Aneurysms that occur in the section of the aorta that runs through the abdomen (abdominal aorta) are called Abdominal Aortic Aneurysms. The portion of the aorta that lies deep inside the abdomen, right in front of the spine, is called the abdominal aorta. Over time, artery walls may become weak and widen. The pressure of blood pumping through the aorta may then cause this weak area to bulge outward, like a balloon (called an aneurysm). An Abdominal Aortic Aneurysm occurs when this type of vessel weakening happens in the portion of the aorta that runs through the abdomen. The majority of Abdominal Aortic Aneurysms result from atherosclerosis, a chronic degenerative disease of the artery wall, in which fat, cholesterol, and other substances build up in the walls of arteries and form soft or hard deposits called plaques.

Abdominal Aortic Aneurysms typically develops slowly over a period of many years and hardly ever cause any noticeable symptoms. Occasionally, especially in thin patients, a pulsating sensation in the abdomen may be felt. The larger an aneurysm grows, the greater the chance it will burst or rupture. People who have this type of aneurysm do not notice it usually, and this is because it typically does not cause any symptoms. Abdominal Aortic Aneurysm may be detected incidentally or at the time of rupture. An arterial aneurysm is defined as a permanent localized dilatation of the vessel at least 150% compared to a relative normal adjacent diameter of that artery

Abdominal Aortic Aneurysm Diagnosis 

Many Abdominal Aortic Aneurysms are accidentally found on ultrasound examinations, x-rays, or CT scans, and the patient is often being examined for an unrelated reason. In other patients who experience symptoms and seek medical attention, a physician may be able to feel a pulsating aorta or hear abnormal sounds in the abdomen with the stethoscope. A physical examination can usually initiate the diagnosis of Abdominal Aortic Aneurysm. The healthcare professional may be able to feel a pulsatile mass in the center of the abdomen and make the clinical diagnosis. In obese patients with a large girth, a physical exam is less helpful. In very thin patients, the aorta can often be seen to pulsate under the skin, and this may be a normal finding. Listening with a stethoscope may also reveal a bruit or abnormal sound from the turbulence of blood within the aneurysm.

Continued in the report…..

Abdominal Aortic Aneurysm Treatment 

Currently, there is no drug therapy to limit the progression of Abdominal Aortic Aneurysm. As an aneurysm grows in size, the aorta wall becomes weaker and weaker, which means surgical intervention may be needed. The goal of any treatment strategy is to prevent the rupture of an aneurysm by controlling its growth. If a large Abdominal Aortic Aneurysm is detected before it ruptures, most people will be advised to have treatment to prevent it from rupturing. 

If the aneurysm is less than 5 cm or 2 inches, the doctor might try to treat it with medication first. They might prescribe drugs, such as beta-blockers and calcium channel blockers, to lower the blood pressure and relax the blood vessels. These medications will lessen the chance of rupture of aneurysm. Indeed, several therapeutic effects of pharmacological agents have been reported in experimental models, and some agents have undergone Abdominal Aortic Aneurysm clinical trials. Treatment with statins, angiotensin-converting enzyme inhibitors, antibiotics, and anti-inflammatory agents appears to inhibit the growth rate of Abdominal Aortic Aneurysm in humans. 

Abdominal Aortic Aneurysm Epidemiology

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Abdominal Aortic Aneurysm Diagnosed Prevalent Population, Total Abdominal Aortic Aneurysm Gender-specific Diagnosed Prevalent Cases, Abdominal Aortic Aneurysm Size-specific Diagnosed Prevalent Cases, and Abdominal Aortic Aneurysm Treatable Population scenario in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2020 to 2034.

Key Findings from the Abdominal Aortic Aneurysm Epidemiological Analysis and Forecast

• Total Diagnosed prevalent population of Abdominal Aortic Aneurysm in 7MM was estimated to be 1,641,380 cases in 2021 and is expected to increase in during the study period [2020–2034].  
• Total diagnosed prevalent cases of Abdominal Aortic Aneurysm in the US were estimated to be 752,408 in 2021, which is the highest among all the 7MM countries
• The US accounted for the highest prevalent population of Abdominal Aortic Aneurysm among 7MM with 8,773 cases in 2021.
• Among the European five countries the total prevalent population of Abdominal Aortic Aneurysm is highest in Germany (192,532), followed by the France (138,193), Italy (68,202) had the lowest prevalent cases among the EU-5 countries.
• Total prevalent population of Abdominal Aortic Aneurysm in Japan was estimated to be 253,883 cases in 2021 and is expected to decrease in during the forecast period [2022–2034].
• In the US, the highest number of cases were found to be having Small ABDOMINAL AORTIC ANEURYSM (3 cm to 4.4 cm across) (696,730 cases) in 2021. Large ABDOMINAL AORTIC ANEURYSM (5.5 cm or more across) were found in the least number of cases, i.e. 3,010 cases in 2021. Around 60,193 cases had Medium ABDOMINAL AORTIC ANEURYSM (4.5 cm to 5.4 cm across) 2021. These cases are expected to increase in the forecast period. 

Abdominal Aortic Aneurysm Epidemiology Segmentation

• Total Abdominal Aortic Aneurysm Diagnosed Prevalent Population
• Total Abdominal Aortic Aneurysm Gender-specific Diagnosed Prevalent Cases
• Abdominal Aortic Aneurysm Size-specific Diagnosed Prevalent Cases
• Abdominal Aortic Aneurysm Treatable Population

Abdominal Aortic Aneurysm Marketed Devices

• AFX® Endovascular ABDOMINAL AORTIC ANEURYSM System: Endologix LLC

The AFX® Endovascular Abdominal Aortic Aneurysm System is an endovascular graft system intended to treat patients with Abdominal Aortic Aneurysm. The device has a unique design in which the metal frame is on the inside of the fabric. It integrates anatomical fixation with an advanced delivery system and graft material technology. AFX® uses a low profile, precise delivery system and proprietary stent graft material (DuraPly™ ePTFE Graft Material) and provides reliable and durable Abdominal Aortic Aneurysm repair. The AFX®2 bifurcated endograft system provides confident control for improved accessibility every step of the way.

Abdominal Aortic Aneurysm Emerging Devices 

• Abdominal Aortic Aneurysm Stent Graft System: Lifetech Scientific

The company’s Abdominal Aortic Aneurysm Stent Graft System is indicated to treat patients with an infrarenal Abdominal Aortic Aneurysm. On September 30, 2018, Lifetech Scientific initiated its trial to evaluate the safety and efficacy of the Abdominal Aortic Aneurysm Stent Graft System for the infrarenal Abdominal Aortic Aneurysm.

• Fenestrated Altura FEVAR Stent Graft: Lombard Medical

Endovascular treatment of aortic diseases has improved in recent years. Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) is an almost new minimally invasive technique for repairing thoracoabdominal or complex Abdominal Aortic Aneurysm.

Abdominal Aortic Aneurysm Market Outlook

Key Findings

• The Abdominal Aortic Aneurysm market size in the 7MM is estimated to be USD 1,579.9 million in 2021, which is further expected to increase by 2034.

• The United States holds the largest Abdominal Aortic Aneurysm market share in the 7MM countries. In 2021, the Abdominal Aortic Aneurysm market size in the US was USD 1,065.7 million.

• In 2021, among the EU-5 countries, Germany had the highest Abdominal Aortic Aneurysm market share, followed by France and the UK.

• Japan holds the smallest share of the 7MM Abdominal Aortic Aneurysm market with a market size of USD 137.8 million in 2021 that is expected to increase by 2034.

The United States: Abdominal Aortic Aneurysm Market Outlook

This section provides the total Abdominal Aortic Aneurysm treatment market size and Abdominal Aortic Aneurysm drugs market size by therapies in the United States.

EU-5: Abdominal Aortic Aneurysm Market Outlook

The total Abdominal Aortic Aneurysm treatment market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom are provided in this section.

Japan: Abdominal Aortic Aneurysm Market Outlook 

The total Abdominal Aortic Aneurysm market size and market size by therapies in Japan are provided.

Abdominal Aortic Aneurysm Pipeline Development Activities 

The Abdominal Aortic Aneurysm pipeline segment provides insights into different therapeutic candidates in phase II and phase III stage. It also analyzes Abdominal Aortic Aneurysm Companies involved in developing targeted therapeutics. 

Reimbursement Scenario

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In the Abdominal Aortic Aneurysm Therapeutics Market Report, we consider reimbursement to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy. 

Abdominal Aortic Aneurysm Competitive Intelligence Analysis 

We perform competitive Abdominal Aortic Aneurysm Therapeutics Market Intelligence analysis of the Abdominal Aortic Aneurysm Drugs Market by using various competitive intelligence tools that include–SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies, etc. The inclusion of the analysis entirely depends upon the data availability.

Abdominal Aortic Aneurysm Therapeutics Market Report Scope

• The Abdominal Aortic Aneurysm Therapeutics Market Report covers a descriptive overview, explaining its causes, symptoms, pathophysiology, genetic basis, diagnosis, and currently available therapies.
• Comprehensive insight has been provided into the Abdominal Aortic Aneurysm epidemiology and treatment.
• Additionally, an all-inclusive account of both the current and emerging therapies for Abdominal Aortic Aneurysms is provided, along with the assessment of new therapies, which will have an impact on the current Abdominal Aortic Aneurysm treatment market landscape.
• A detailed review of the Abdominal Aortic Aneurysm Drugs Market; historical and forecasted is included in the report, covering the 7MM drug outreach.
• Detailed Patient-Based Abdominal Aortic Aneurysm Market Forecasting determines the trends shaping and driving the 7MM Abdominal Aortic Aneurysm Drugs Market.

Abdominal Aortic Aneurysm Drugs Market Report Highlights

• The robust Abdominal Aortic Aneurysm pipeline with novel MOA and oral ROA, increasing prevalence, and effectiveness of drugs will positively drive the Abdominal Aortic Aneurysm Drugs Market.
• The Abdominal Aortic Aneurysm Companies and academics are working to assess challenges and seek opportunities that could influence Abdominal Aortic Aneurysm R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition.
• Abdominal Aortic Aneurysm Companies are involved in developing therapies for Abdominal Aortic Aneurysm. The launch of Abdominal Aortic Aneurysm emerging therapies will significantly impact the Abdominal Aortic Aneurysm Drugs Market.
• Our in-depth analysis of the pipeline assets across different stages of development (phase III and phase II), different emerging trends, and comparative analysis of pipeline products with detailed Abdominal Aortic Aneurysm clinical trials profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.

Abdominal Aortic Aneurysm Therapeutics Market Report Insights

• Patient-Based Abdominal Aortic Aneurysm Market Forecasting
• Therapeutic Approaches
• Abdominal Aortic Aneurysm Pipeline Analysis
• Abdominal Aortic Aneurysm Market Size
• Abdominal Aortic Aneurysm Market Trends
• Abdominal Aortic Aneurysm Market Opportunities

Abdominal Aortic Aneurysm Therapeutics Market Report Key Strengths

• 10 Years Abdominal Aortic Aneurysm Market Forecast
• 7MM Coverage 
• Abdominal Aortic Aneurysm Epidemiology Segmentation
• Key Cross Competition 
• Highly Analyzed Abdominal Aortic Aneurysm Therapeutics Market

Abdominal Aortic Aneurysm Treatment Market Report Assessment

• Current Abdominal Aortic Aneurysm Treatment Market Practices
• Abdominal Aortic Aneurysm Unmet Needs
• Abdominal Aortic Aneurysm Pipeline Drugs Profiles
• Abdominal Aortic Aneurysm Therapeutics Market Attractiveness
• Abdominal Aortic Aneurysm Market Drivers
• Abdominal Aortic Aneurysm Market Barriers
• Abdominal Aortic Aneurysm SWOT analysis

Key Questions Answered in the Abdominal Aortic Aneurysm Market Report

Abdominal Aortic Aneurysm Treatment Market Insights:

• What was the Abdominal Aortic Aneurysm drugs market share (%) distribution in 2020 and how it would look like in 2034?
• What would be the Abdominal Aortic Aneurysm treatment market size as well as market size by therapies across the 7MM during the forecast period (2023–2034)?
• What are the key findings pertaining to the market across the 7MM and which country will have the largest Abdominal Aortic Aneurysm market size during the forecast period (2023–2034)?
• At what CAGR, the Abdominal Aortic Aneurysm therapeutics market is expected to grow at the 7MM level during the forecast period (2023–2034)?
• What would be the Abdominal Aortic Aneurysm market outlook across the 7MM during the forecast period (2023–2034)?
• What would be the Abdominal Aortic Aneurysm market growth till 2034 and what will be the resultant market size in the year 2034?
• How would the market drivers, barriers, and future opportunities affect the Abdominal Aortic Aneurysm market dynamics and subsequent analysis of the associated trends?

Abdominal Aortic Aneurysm Epidemiology Insights:

• What are the disease risks, burdens, and Abdominal Aortic Aneurysm unmet needs?
• What is the historical Abdominal Aortic Aneurysm patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
• What would be the forecasted patient pool of Abdominal Aortic Aneurysm at the 7MM level?
• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Abdominal Aortic Aneurysm?
• Out of the above-mentioned countries, which country would have the Abdominal Aortic Aneurysm highest population during the forecast period (2023–2034)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2023–2034)?

Current Abdominal Aortic Aneurysm Treatment Market Scenario, Marketed Drugs, and Emerging Therapies:

• What are the current options for the treatment of Abdominal Aortic Aneurysmalong with the approved therapy?
• What are the current treatment guidelines for the treatment of Abdominal Aortic Aneurysm?
• What are the key collaborations (Industry–Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Abdominal Aortic Aneurysm therapies? 
• What are the 7MM historical and forecasted Abdominal Aortic Aneurysm Market?

Reasons to Buy the Abdominal Aortic Aneurysm Market Report

• The Patient-Based Abdominal Aortic Aneurysm Market Forecasting analysis will help in developing business strategies by understanding trends shaping and driving Abdominal Aortic Aneurysm.
• To understand the future market competition in the Abdominal Aortic Aneurysm Treatment Market and an insightful review of the key market drivers and barriers.
• Organize sales and marketing efforts by identifying the best opportunities for Abdominal Aortic Aneurysm in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
• Identification of strong upcoming players in the Abdominal Aortic Aneurysm Treatment Market will help in devising strategies that will help in getting ahead of competitors.
• Organize sales and marketing efforts by identifying the best opportunities for the Abdominal Aortic Aneurysm Treatment Market.
• To understand the future market competition in the Abdominal Aortic Aneurysm Treatment Market.

Read Our Latest Articles-

• Discovering the Latest Developments in the Rapidly Advancing Abdominal Aortic Aneurysm Treatment Landscape
• Abdominal Aortic Aneurysm Market: Infographics
• New DelveInsight Blogs